N/OFQ-NOP System in Peripheral and Central Immunomodulation.

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Classical opioids (mu, delta, kappa) are known peripheral immune depressants with central roles in neuropathic pain.
• Nociceptin/Orphanin FQ (N/OFQ) and its receptor (NOP) are implicated in modulating immune function centrally and peripherally.
• NOP activation on circulating immune cells influences immune responses, distinct from classical opioids.

Purpose of the Study:

• To explore the immunomodulatory roles of classical opioids and the N/OFQ-NOP system.
• To investigate the central and peripheral mechanisms by which these systems affect immune function.
• To assess the therapeutic potential of targeting these systems in neuropathic pain and inflammatory diseases.

Main Methods:

• Review of existing literature on opioid and N/OFQ-NOP system interactions with immune cells.
• Analysis of evidence for central and peripheral immunomodulation by classical opioids and N/OFQ.
• Examination of NOP expression and function on various immune cell types and glial cells.

Main Results:

• Classical opioids generally suppress immune function peripherally.
• NOP activation peripherally depresses immune function, partly via circulating immune cells, with implications for asthma and sepsis.
• Central NOP activation modulates glial function, reducing microglia activation in pain and trauma models, and interacts with astrocytes.

Conclusions:

• Both classical opioids and the N/OFQ-NOP system possess significant immunomodulatory capacity.
• NOP activation on immune cells offers a distinct mechanism for immune modulation compared to classical opioids.
• Targeting the N/OFQ-NOP system presents potential for managing neuropathic pain and inflammatory conditions by modulating central and peripheral immunity.